SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-21-000025
Filing Date
2021-07-28
Accepted
2021-07-28 07:01:37
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myov-20210630.htm   iXBRL 10-Q 1527462
2 EX-10.2 exhibit102-letteragreement.htm EX-10.2 18341
3 EX-31.1 a06302021myovantex311.htm EX-31.1 10703
4 EX-31.2 a06302021myovantex312.htm EX-31.2 10893
5 EX-32.1 a06302021myovantex321.htm EX-32.1 6490
6 EX-32.2 a06302021myovantex322.htm EX-32.2 6293
12 image.jpg GRAPHIC 8669
13 image1.jpg GRAPHIC 29035
  Complete submission text file 0001679082-21-000025.txt   6438764

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20210630.xsd EX-101.SCH 54412
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20210630_cal.xml EX-101.CAL 57561
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20210630_def.xml EX-101.DEF 248518
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20210630_lab.xml EX-101.LAB 564437
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20210630_pre.xml EX-101.PRE 373077
14 EXTRACTED XBRL INSTANCE DOCUMENT myov-20210630_htm.xml XML 897713
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 211119806
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences